Comerica Bank’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-389
| Closed | -$49K | – | 2304 |
|
2020
Q1 | $49K | Buy |
389
+17
| +5% | +$2.14K | ﹤0.01% | 2216 |
|
2019
Q4 | $95K | Sell |
372
-3
| -0.8% | -$766 | ﹤0.01% | 2240 |
|
2019
Q3 | $90K | Buy |
375
+69
| +23% | +$16.6K | ﹤0.01% | 2231 |
|
2019
Q2 | $253K | Sell |
306
-21
| -6% | -$17.4K | ﹤0.01% | 2131 |
|
2019
Q1 | $502K | Buy |
327
+8
| +3% | +$12.3K | ﹤0.01% | 1882 |
|
2018
Q4 | $597K | Sell |
319
-2
| -0.6% | -$3.74K | 0.01% | 1799 |
|
2018
Q3 | $702K | Sell |
321
-93
| -22% | -$203K | 0.01% | 1754 |
|
2018
Q2 | $1.47M | Buy |
414
+3
| +0.7% | +$10.7K | 0.01% | 1458 |
|
2018
Q1 | $1.15M | Buy |
411
+12
| +3% | +$33.7K | 0.01% | 1562 |
|
2017
Q4 | $1.3M | Sell |
399
-11
| -3% | -$35.8K | 0.01% | 1513 |
|
2017
Q3 | $1.34M | Buy |
410
+3
| +0.7% | +$9.83K | 0.01% | 1464 |
|
2017
Q2 | $1.1M | Sell |
407
-21
| -5% | -$56.5K | 0.01% | 1529 |
|
2017
Q1 | $799K | Buy |
428
+18
| +4% | +$33.6K | 0.01% | 1702 |
|
2016
Q4 | $1.05M | Buy |
410
+21
| +5% | +$53.9K | 0.01% | 1559 |
|
2016
Q3 | $966K | Buy |
389
+5
| +1% | +$12.4K | 0.01% | 1513 |
|
2016
Q2 | $1.11M | Sell |
384
-4
| -1% | -$11.5K | 0.01% | 1432 |
|
2016
Q1 | $1.33M | Buy |
388
+23
| +6% | +$78.8K | 0.01% | 1314 |
|
2015
Q4 | $1.76M | Sell |
365
-5
| -1% | -$24.2K | 0.02% | 1063 |
|
2015
Q3 | $1.18M | Sell |
370
-382
| -51% | -$1.21M | 0.01% | 1345 |
|
2015
Q2 | $3.01M | Buy |
752
+390
| +108% | +$1.56M | 0.01% | 1277 |
|
2015
Q1 | $1.45M | Sell |
362
-338
| -48% | -$1.35M | 0.01% | 1282 |
|
2014
Q4 | $3.43M | Buy |
700
+344
| +97% | +$1.69M | 0.01% | 1161 |
|
2014
Q3 | $1.45M | Buy |
356
+5
| +1% | +$20.3K | 0.01% | 1279 |
|
2014
Q2 | $1.42M | Sell |
351
-2
| -0.6% | -$8.09K | 0.01% | 1303 |
|
2014
Q1 | $1.6M | Sell |
353
-10
| -3% | -$45.4K | 0.01% | 1284 |
|
2013
Q4 | $1.27M | Sell |
363
-38
| -9% | -$133K | 0.01% | 1417 |
|
2013
Q3 | $1.65M | Buy |
401
+8
| +2% | +$32.8K | 0.01% | 1285 |
|
2013
Q2 | $1.56M | Buy |
+393
| New | +$1.56M | 0.01% | 1109 |
|